Latest News
-
2 Multibagger Defence To Shield Your Money, Buy On April 24; Prabhudas Sets Target Prices, Stop Loss -
Rs 3.5/Share Dividend Declared: NBFC Declares 55.5% YoY Surge In PAT, Shares Up 87% In 1-Yr -
Rs 118/Share Dividend: Healthcare Stock Below Rs 400 Turned Ex-Dividend, Payout Soon; Buy For Rs 515 Target -
6,693% Returns: Below Rs 75, Pharma Penny Stock Ex-Dividend For Rs 40/Sh Payout After 9 Years; Do You Own? -
TCS Vs Infosys Vs Wipro Shares, ADRs, Upcoming Dividends: Which Mega IT Stocks To Buy After Q4 Results? -
SBI Card Launches 3 New Variants of Its Travel Credit Card ‘SBI Card MILES’ -
25% Dividend Record Date: Logistic Stock Nears 1-Year High And It Belongs To Mahindra; Motilal Neutral -
1:10 Split, 26 Dividends: Tata's 26-Year-Old Retail Stock In Focus, Q4, Dividend Ahead; Buy For Target Rs 4200 -
1:5 Split Soon: Rs 2,300 Defence Stock To Split Into Five Shares, Rs 400 Cr Fundraising Too; Hits 52-Week High -
Penny Stock Bags Back-To-Back Orders Worth Rs 500 Mn, 110 Mn; Shares Hit Upper Circuit
Infosys Share Price Hits New All-Time High
Shares of Infosys Ltd, the second-largest software company in India rose as much as 1.6 percent to hit a record high of Rs 766.95 apiece, its highest ever. The stock's previous high was recorded at Rs 759.8 per share.
The movement was seen after a two-day fall aiding the climb of NSE's benchmark Nifty 50's gain beyond the 11,000 mark. Analysts have projected that the prices could move further upwards.
In the last 12 months, the stock has given its investors a return of 33 percent. The Relative Strength Index which was above 70, indicated that the stock may be overbought.
As of last's day close, shares of Infosys were trading 15.18 percent for 2019 while NSE's broader index only moved 0.66 percent higher.
Apart from external factors like the weakness in European financial services, strong results reported by the IT giant for the third quarter of 2018-19, have thrown light on the company's focus to diversify the revenue concentration, say experts. Its growth trajectory for the next 12 to 18 months looks positive.
